Diabetic Nephropathy Type 2 Clinical Trial
Official title:
A Multicentric, Prospective, Randomized Study Evaluating the Improvement of Renal Function Outcomes With Dorzagliatin in Patients With Type 2 Diabetes Mellitus With Early Kidney Injury.
The main purpose of this study is to explore the improvement of renal function before and after the intervention of dorzagliatin in patients with type 2 diabetes.
As soon，metformin、SGLT-2i、GLP-1RA have been confirmed to have protective effect on the kidneys in the statement of consensus at home and abroad. Dorzagliatin exerts a potent hypoglycemic effect by activating glucokinase and is not affected by the patient's renal function. However, previous studies of this drug have rarely involved studies that improve markers related to renal function. On the one hand, in this study, changes of renal function (eGFR, creatinine, cystatin C, TNF-1) are collected to investigate whether dorzagliatin is benefit to kidney. On the other hand, renal magnetic resonance imaging(MRI) results are analysed to explore the differences among control subjects and patients treated with dorzagliatin. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03840343 -
Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease
|
Phase 1 | |
| Completed |
NCT04549324 -
Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy
|
||
| Recruiting |
NCT03502031 -
Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy
|
Phase 4 | |
| Completed |
NCT03681704 -
the Integrated Traditional Chinese and Western Medicine Treat Early Stage DKD
|
Phase 1 | |
| Completed |
NCT03681249 -
the Integrated Traditional Chinese and Western Medicine Treat Middle Stage DKD
|
Early Phase 1 | |
| Withdrawn |
NCT03504566 -
Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)
|
Phase 4 | |
| Completed |
NCT03889236 -
Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.
|
N/A | |
| Completed |
NCT06326034 -
Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients
|
Phase 4 | |
| Recruiting |
NCT04931537 -
Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics.
|
||
| Not yet recruiting |
NCT05373004 -
Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03622762 -
Green Tea Extract on Soluble RAGE in Patients With Diabetic Nephropathy
|
Phase 2 | |
| Recruiting |
NCT03445247 -
Extracorporeal Low-intensity Shockwave in Diabetic Nephropathy
|
N/A | |
| Not yet recruiting |
NCT06068439 -
Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04143412 -
Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination
|
Phase 2 | |
| Completed |
NCT05487755 -
Investigational and Comparative Study in the Management of Diabetic Nephropathy
|
Phase 3 | |
| Active, not recruiting |
NCT04573920 -
Atrasentan in Patients With Proteinuric Glomerular Diseases
|
Phase 2 | |
| Recruiting |
NCT05888909 -
Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy
|
||
| Not yet recruiting |
NCT04962399 -
Relationship Between Serum N/OFQ and Type 2 Diabetic Nephropathy
|
||
| Not yet recruiting |
NCT03591939 -
T-regulatory Cells in Diabetic Type Two Nephropathy
|
||
| Active, not recruiting |
NCT03859817 -
Observational Study to Evaluate the Relationship Between Ketonemia and Renal Function in the Diabetic Patient
|